David B Peden Selected Research

Leukemia

4/2016

Successful use of palifermin following severe anaphylaxis to pegaspargase in a pediatric patient with acute lymphoblastic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David B Peden Research Topics

Disease

45	Asthma (Bronchial Asthma) 01/2023 - 08/2002
41	Inflammation (Inflammations) 11/2023 - 08/2002
7	Hypersensitivity (Allergy) 02/2021 - 12/2002
6	Infections 01/2023 - 08/2002
5	Lung Diseases (Lung Disease) 11/2023 - 04/2008
3	COVID-19 01/2023 - 05/2020
2	Obesity 10/2021 - 12/2019
2	Disease Progression 12/2019 - 07/2011
2	Burns 05/2015 - 01/2013
2	Inhalation Burns 05/2015 - 01/2013
2	Pneumonia (Pneumonitis) 03/2015 - 12/2010
2	Allergic Rhinitis 10/2011 - 06/2009
2	Chronic Obstructive Pulmonary Disease (COPD) 09/2009 - 04/2008
2	Cystic Fibrosis (Mucoviscidosis) 04/2008 - 01/2006
1	Hyperemia 02/2024
1	Chronic Bronchitis 11/2022
1	Neoplasms (Cancer) 01/2022
1	Asymptomatic Infections 01/2020
1	Atopic Dermatitis (Atopic Eczema) 12/2019
1	Eosinophilia 01/2018
1	Respiratory Tract Infections (Respiratory Tract Infection) 12/2017
1	Anaphylaxis (Anaphylactic Shock) 04/2016
1	Mucositis 04/2016
1	Leukemia 04/2016
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2016
1	Virus Diseases (Viral Diseases) 10/2015
1	Drug-Related Side Effects and Adverse Reactions 05/2014
1	Lung Injury 03/2014
1	Human Influenza (Influenza) 10/2012

Drug/Important Bio-Agent (IBA)

20	OzoneIBA 11/2023 - 08/2002
16	EndotoxinsIBA 11/2023 - 08/2002
13	Environmental Pollutants (Pollutants, Environmental)IBA 12/2019 - 08/2002
11	AllergensIBA 11/2023 - 06/2006
8	Particulate MatterIBA 04/2022 - 08/2002
7	SmokeIBA 11/2023 - 09/2009
7	Air Pollutants (Pollutants, Air)IBA 11/2023 - 08/2002
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2004
5	gamma-TocopherolIBA 01/2020 - 10/2007
5	CytokinesIBA 01/2018 - 12/2002
4	Vitamin E FDA LinkGeneric 11/2023 - 07/2013
4	AntioxidantsIBA 01/2018 - 10/2007
3	Tocopherols (Tocopherol)IBA 11/2023 - 01/2013
3	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2021 - 06/2008
3	Glutathione Transferase (Glutathione S-Transferase)IBA 01/2019 - 12/2009
3	Interleukin-10 (Interleukin 10)IBA 05/2015 - 12/2010
3	InflammasomesIBA 10/2012 - 07/2011
3	ChemokinesIBA 06/2012 - 02/2006
2	Protein Isoforms (Isoforms)IBA 11/2023 - 01/2018
2	Antiviral Agents (Antivirals)IBA 01/2023 - 10/2012
2	VaccinesIBA 01/2023 - 02/2021
2	Prednisone (Sone)FDA LinkGeneric 04/2022 - 10/2021
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2022 - 03/2008
2	Vehicle Emissions (Emissions, Vehicle)IBA 05/2014 - 08/2002
2	Interleukin-13IBA 05/2014 - 06/2012
2	Therapeutic UsesIBA 03/2014 - 10/2007
2	LipopolysaccharidesIBA 03/2014 - 02/2011
2	Interleukin-6 (Interleukin 6)IBA 10/2012 - 09/2002
2	Proteins (Proteins, Gene)FDA Link 08/2012 - 01/2006
2	Toll-Like Receptor 4IBA 07/2011 - 09/2010
2	Messenger RNA (mRNA)IBA 12/2010 - 06/2006
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 09/2008 - 03/2008
2	AntigensIBA 06/2008 - 03/2008
2	HLA-DR Antigens (HLA-DR)IBA 03/2008 - 06/2006
1	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 01/2022
1	IonophoresIBA 01/2022
1	ProstaglandinsIBA 01/2022
1	LeukotrienesIBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2020
1	Immunoglobulin E (IgE)IBA 12/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2019
1	Nitrogen OxidesIBA 12/2019
1	Amyloid (Amyloid Fibrils)IBA 01/2019
1	C-Reactive ProteinIBA 01/2019
1	SteroidsIBA 01/2018
1	MucinsIBA 01/2018
1	Fibroblast Growth Factor 7 FDA Link 04/2016
1	pegaspargase (Oncaspar)FDA Link 04/2016
1	NF-E2-Related Factor 2IBA 01/2016
1	sulforaphaneIBA 01/2016
1	isothiocyanic acidIBA 01/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	Interleukin-1 (Interleukin 1)IBA 10/2015
1	ErbB Receptors (EGF Receptor)IBA 03/2015
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 02/2015
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 02/2015
1	MicroRNAs (MicroRNA)IBA 06/2014
1	lebrikizumabIBA 05/2014
1	montelukast (Singulair)FDA Link 05/2014
1	Bronchodilator Agents (Bronchodilators)IBA 05/2014
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 08/2012
1	glutathione S-transferase M1IBA 08/2012
1	Interleukin-8 (Interleukin 8)IBA 08/2012
1	Small Interfering RNA (siRNA)IBA 08/2012
1	Chemokine CCL26IBA 06/2012

Therapy/Procedure

11	Therapeutics 01/2023 - 10/2007
2	Artificial Respiration (Mechanical Ventilation) 05/2015 - 01/2013
1	Aftercare (After-Treatment) 02/2024
1	Precision Medicine 01/2021
1	Biological Therapy 05/2020
1	Bronchial Thermoplasty 05/2014